4Front Ventures Corp. · OTC:FFNTF
4Front Ventures — Investor Presentation (July 2019)
28 slides from 4Front Ventures's investor presentation, July 2019

Slide 1: 4Front - A Mass Market Platform for Consumer Cannabis
4Front - A Mass Market Platform for Consumer Cannabis Investor Presentation CSE: FFNT / OTCQX: FFNTF

Slide 2: Disclaimer
Disclaimer Information in this presentation is about 4Front (“4Front”), its acting on their behalf, are expressly qualified in their entirety by the been formed. Although these personal opinions may be useful for principals, its business and the industry in which it is a participant. The cautionary

Slide 3: Disclaimer contd.
Disclaimer contd. Adjusted EBITDA is defined by 4Front as earnings before interest, more information, please refer to Cannex Capital Holdings, Inc., Listing • The timing of completion of the Company’s infrastructure projects, taxes, depreciation and amortization less share-based compensation Stateme

Slide 4: 4Front at a Glance
4Front at a Glance Founded as a consulting company to assist clients in obtaining cannabis licenses, 2011 utilizing standard operating procedures from the famed Harborside dispensary Evolved to obtaining and operating its 2015 own cannabis assets July Completed merger with Cannex, bringing 2019 batt

Slide 5: 4Front's Thesis
4Front's Thesis • We believe that execution with a focus on low-cost production and supply chain management should result in the creation of significant shareholder value. • We are taking battle-tested operations – proven low cost, quality production of mass market cannabis products – and replicatin

Slide 6: The New 4Front: Prepared for Mass Market Leadership
The New 4Front: Prepared for Mass Market Leadership Infrastructure Retail Efficient build outs of high- Operate 11 dispensaries across yield cultivation and production 7 states facilities Production >20 Brands with >300 SKUs Mission Driven currently sold in >60% of Washington Long history of credibl

Slide 7: Four Pillars of 4Front
Four Pillars of 4Front Battle-Tested: Ability to produce high-quality, low-cost cannabis products at Leadership: scale Prioritize smart stewardship of capital and value creation for shareholders Magnet for Talent: Mission-driven culture matters Strategic Asset Base: Adult-use leaning asset base with

Slide 8: Production: Efficient Operations at Scale
Production: Efficient Operations at Scale Elma cultivation facility, Washington Tumwater production facility, Washington Operations Matter Brightleaf 4Front | A Mass Market Platform for Consumer Cannabis 8

Slide 9: Production: Efficient Operations at Scale
Production: Efficient Operations at Scale The Brightleaf team has been reducing the costs of cannabis production for years. When Washington’s wholesale price for cannabis plummeted roughly 70% to a low of $520/lb. in 2017, high-cost producers began shuttering operations. But the Brightleaf facilitie

Slide 10: Production: Efficient Operations at Scale
Production: Efficient Operations at Scale The Flagship Facilities in Washington, v1.0 and v2.0 - Yield & Production1 Cost per Gram Significantly Lower than Major Canadian LPs 2 Production/kg Yield g/sq. ft. The 2018 Elma facility (v2.0) was Facilities produce quality (high terpene 37% cheaper to bui

Slide 11: Production: Diverse and Consistent Mix of Mass Market Brands
Production: Diverse and Consistent Mix of Mass Market Brands “... we would highlight Northwest Cannabis Solutions, which is in the top 10 for flower, capsules, pre-rolls, and vapor pens.” – Vivien Azer, Cowen Equity Research Operations Matter Brightleaf 4Front | A Mass Market Platform for Consumer C

Slide 12: Strong Brands Across All Product Types
Strong Brands Across All Product Types Operations Matter Brightleaf 4Front | A Mass Market Platform for Consumer Cannabis 12

Slide 13: Materializing in Massachusetts
Materializing in Massachusetts August 2019 September 2019 October 2019 December 2019 February 2020 Cannex operations team Marmas and Pebbles, First harvest from Premium Brightleaf Premium Brightleaf becomes the Brightleaf two of Washington’s 4Front’s Worcester flower strains infused flower division

Slide 14: Mission: Mission-Driven Retail
Mission: Mission-Driven Retail 11 Mission retail was created to provide cannabis consumers of all types access to quality, low-cost products in a warm, welcoming environment. Chicago, IL • 4Front’s retail and regulatory expertise trace Dispensaries by YE 2019 7 back to the iconic Harborside dispensa

Slide 15: Pure Ratios: Cannabinoids for Wellness
Pure Ratios: Cannabinoids for Wellness Founded in 2015, Pure Ratios focuses on holistic wellness products that marry cannabinoids with traditional Eastern medicine ingredients, as well as hemp-derived CBD products that are sold nationwide. Chad Conner, co-founder • Focused suite of wellness products

Slide 16: Building Our Strategic Asset Base
Building Our Strategic Asset Base Focus on key markets where we can achieve operational efficiency at scale Licensed facilities anticipated by YE 2020 States Cultivation & Production Retail Washington 3 0 Illinois 1 2 Michigan 0 1 California 1 0 Massachusetts 2 6¹ Massachusetts California Illinois M

Slide 17: Committed, Experienced and Aligned Management
Committed, Experienced and Aligned Management Leo Gontmakher - CEO Andrew Thut - CIO, 4Front Leo co-founded Northwest Cannabis Solutions, which under his Andrew was an early investor in 4Front, joining the company leadership grew to be one of the largest and most successful full time in 2014. He bri

Slide 18: Strong Independent Board Members
Strong Independent Board Members Josh Rosen – Executive Chairman Eric Rey – Chairman & Director Josh spent 13 years as an equity analyst and portfolio manager Eric is a director and consultant to Arcadia Biosciences, Inc. in the financial services industry, during which time he became where he previ

Slide 19: The Evolution of Cannabis in the Capital Markets: Identifying the Winners
The Evolution of Cannabis in the Capital Markets: Identifying the Winners Cannabis 1.0 Cannabis 2.0 Cannabis 3.0 • “Funded capacity” • Management resumes We believe how cannabis companies are valued will • License portfolio evolve from a focus on • Total Addressable Market assets to how well they’re

Slide 20: Others Zigged While We Zagged
Others Zigged While We Zagged While competitors sought to plant flags in as many jurisdictions as possible to chase “total addressable market,” we focused on prudent but aggressive growth, acquired battle-tested operational skills in Cannex, and continued to focus on the key markets that we believe

Slide 21: Contact
Contact Andrew Thut Chief Investment Officer, 4Front 617.413.0069 andrew.thut@4frontventures.com Conclusion 21

Slide 22: Appendices
© “~ 4FRONT Appendices

Slide 23: Guidance 2020 & 2021
Guidance 2020 & 2021 Base Case = Our plan based upon current modest incremental capital needs of $30 million and the assumption we remain in a relatively capital constrained environment. 2020 2021 Systemwide Pro Forma Revenue $140-180M $250-300M IFRS Revenue $100-140M $200-250M Adjusted EBITDA $10-1

Slide 24: Capitalization Table
Capitalization Table 4Front Shares I/O Cash (CAD) Price Shares As-Converted Shares Subordinate Voting Shares 120,408,927 120,408,927 Proportionate Voting Shares 5,114,591 409,167,282 Multiple Voting Shares 1,276,208 1,276,208 Total Basic Shares Outstanding 126,799,726 530,852,417 Total As-Converted

Slide 25: US Cannabis Market
US Cannabis Market The U.S. Cannabis market is growing rapidly. The majority of states already have some form of legal cannabis. Adult Use/Recreational Medical CBD Only No Legal Cannabis The U.S. cannabis market is expected to be US$75 Billion by 20301 1 Cowen Inc., April 2018 report: “Cannabis: $75

Slide 26: US Market Potential
US Market Potential 1 Cannabis Beer Wine & Spirits $75B+ Coffee $100B+ $100B+ 14% Penetration $50B+ 25% Penetration 20% Penetration 50% Penetration 1Market size based on Brewers Association (beer), Park Street (wine and spirits), Ackrell Capital (coffee), Cowen Group (cannabis). Penetration rates ba

Slide 27: US Support for Legalization
US Support for Legalization 60 of Americans Live in a state where % 20 of Americans % Live in a state where 94 of Americans % Support legalizing 64 of Americans % Support fully legalizing Marijuana is legal in Marijuana is legal for Medical Marijuana 3 Marijuana 4 some form 1 adult use 2 1 PolitiFac

Slide 28: The Global Cannabis Landscape
The Global Cannabis Landscape Medical & Recreational Medical United States "The global legal cannabis market is projected to be worth up to US$103.9 billion by 2024." – The Global Cannabis Report, Nov 2019, Prohibition Partners. Opportunity 4Front | A Mass Market Platform for Consumer Cannabis 28
Source: Internet Archive copy of 4frontventures.com
More decks from 4Front Ventures Corp.
Investor Presentation (November 2024)24 slides · November 2024
Investor Presentation (June 2024)20 slides · June 2024
Investor Presentation (April 2024)20 slides · April 2024
Investor Presentation (January 2024)18 slides · Jan 19, 2024
Investor Presentation (December 2022)34 slides · December 2022
Investor Presentation (August 2022)34 slides · August 2022